Key Market Indicators
Since 2005, Swazi exports decreased by an average of 3.2% year on year. Malta overtook in 2016, with $722.14. The United States, the United Kingdom and Germany respectively were numbers 2, 3 and 4 in this ranking. By 2026, Swazi vaccination coverage is expected to reach 84% of children aged one year old, down from 84% in 2021. The average annual decrease from 2005 to 2021 was 1.4%. Vaccination coverage is projected to remain stable at 89% for children aged one year old from 2021 to 2026. The average annual decrease from 1986 to 2021 was 0.2%. Swazi vaccine imports are forecast to reach $5.46 million in 2026, up from $4.4 million in 2021, with an average annual growth rate of 3.7% from 2005 to 2021. The country was ranked 110th in 2021, with Malta overtaking with $4.4 million. The United States, the United Kingdom and Germany ranked second, third and fourth, respectively. Swazi vaccine exports decreased from $4,980 in 2015 to nearly $722 in 2016, a 3.2% average annual decrease since 2005. Malta overtook in 2016, with $722. The United States, the United Kingdom and Germany ranked second, third and fourth, respectively.
Swaziland Vaccine Market Data and Forecasts
How much will Swaziland Vaccine Market grow to 2026?
More in Vaccine Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
Pharmaceutical Innovation: Exploring Synergies in Antibiotics and Antibody Drugs Development
Innovation in the pharmaceutical sector, specifically within antibiotics and antibody drugs, is fuelled by a multitude of factors. Increasing antimicrobial resistance necessitates the development of new antibiotics, while complex diseases like cancer and autoimmune disorders demand advanced immunotherapies. Continuous advances in technology and science also play a crucial role, alongside...
Discover more insights -
Vaccine Market Insights: Exploring Trends in Pneumococcal and Meningococcal Immunization
The pneumococcal vaccine market is predominantly driven by the escalating global burden of pneumococcal diseases, including pneumonia, meningitis, and sepsis. With pneumococcal bacteria as a leading cause of vaccine-preventable deaths worldwide, policymakers and health organizations are ramping up immunization drives, amplifying vaccine demand. Furthermore, the introduction of innovative vaccine variants—quelling...
Discover more insights -
Vaccines Market: Insights into Global Trends and Emerging Forecast Practices
Worldwide, the vaccine market is propelled forward by a combination of public health imperatives, advances in vaccine development technologies, and various market incentives. Increased rate of infectious diseases boosts the demand for vaccines, thereby expanding the markets. The swift focus on the development and distribution of COVID-19 vaccines is a...
Discover more insights -
Travel Vaccines Market: A Comprehensive Review on Growth, Trends, and Forecast Opportunities
The market for travel vaccines is fundamentally driven by the swelling global mobility and increased exposure to infectious diseases in developing countries. Effectively, as more people venture overseas, either due to recreational, educational, or business reasons, there is an escalated demand for specialized vaccinations. This market dynamic also reflects the...
Discover more insights -
Global Health Initiatives: The Transformative Impact and Industry Dynamics of Dengue Vaccines
The dengue vaccine market unravels unparalleled potential towards altering the global public health landscape. The vaccine, formulated to combat one of the most common mosquito-borne illnesses worldwide, bears significant potential to diminish morbidity and mortality. Additionally, the proliferation of such vaccines could catalyze a substantial reduction in healthcare expenses linked...
Discover more insights